Search alternatives:
web decrease » we decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
Showing 14,021 - 14,040 results of 101,041 for search '(( a web decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.29s Refine Results
  1. 14021
    Cu ions inhibit Prs.

    Cu ions inhibit Prs. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  2. 14022
    Adverse events in low-dose naltrexone arm.

    Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
    Save to List
    Saved in:
  3. 14023
    CONSORT flow diagram.

    CONSORT flow diagram. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
    Save to List
    Saved in:
  4. 14024
    Adverse events in placebo arm.

    Adverse events in placebo arm. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
    Save to List
    Saved in:
  5. 14025
    Adverse events in gabapentin arm.

    Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

    Published 2024
    “…</p><p>Clinical trial registration</p><p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT4052139" target="_blank">NCT4052139</a>).…”
    Save to List
    Saved in:
  6. 14026
    Copper detoxification contributes to <i>S</i>. <i>aureus</i> pathogenesis.

    Copper detoxification contributes to <i>S</i>. <i>aureus</i> pathogenesis. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  7. 14027
    Time-dependent effects of pre-exposure to rotenone.

    Time-dependent effects of pre-exposure to rotenone. by Joseph A. Covi (3131166)

    Published 2016
    Save to List
    Saved in:
  8. 14028
    T2D case-control analyses of up to 5,777 patients from Inter99 (n = 320), Health 2006 (n = 166), Health 2008 (n = 18), Steno Diabetes Center (n = 1,424), ADDITION (n = 1,870) and Vejle Biobank (n = 1,979) and up to 7,956 individuals with normal fasting glucose from Inter99 (n = 4,590), Health 2006 (n = 2,412), Health 2008 (n = 528) and Vejle Biobank (n = 426).

    T2D case-control analyses of up to 5,777 patients from Inter99 (n = 320), Health 2006 (n = 166), Health 2008 (n = 18), Steno Diabetes Center (n = 1,424), ADDITION (n = 1,870) and V... by Marie Neergaard Harder (232759)

    Published 2015
    Save to List
    Saved in:
  9. 14029
    Genetically altering the demand for PRPP modulates the sensitivity to Cu(II).

    Genetically altering the demand for PRPP modulates the sensitivity to Cu(II). by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  10. 14030
    5-year persistence of innate immune responses to VZV-gE after RZV administration. Data were derived from 14 RZV recipients who received 2 doses of vaccine at Days 0 and 60. Demographic characteristics of the participants are presented in S3 Table. The graphs show the frequencies of activated cells in VZV-rgE-stimulated conditions after subtraction of medium control. p values were calculated using mixed effects analysis and FDR correction for multiple comparisons.

    5-year persistence of innate immune responses to VZV-gE after RZV administration. Data were derived from 14 RZV recipients who received 2 doses of vaccine at Days 0 and 60. Demogra... by Michael J. Johnson (5818168)

    Published 2025
    Save to List
    Saved in:
  11. 14031
    Growth with Cu(II) alters pentose phosphate pathway function.

    Growth with Cu(II) alters pentose phosphate pathway function. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  12. 14032
    eGFR trajectories by type of physical activity.

    eGFR trajectories by type of physical activity. by Ronit Calderon-Margalit (584756)

    Published 2025
    “…</p><p>Results</p><p>During 9.5 years of follow-up, the eGFR decreased by 0.97 ml/min/1.73m<sup>2</sup> per year. …”
    Save to List
    Saved in:
  13. 14033
    Level of stress before March 2020 and after (Willcox test).

    Level of stress before March 2020 and after (Willcox test). by Łukasz Kołodziej (5329022)

    Published 2021
    Save to List
    Saved in:
  14. 14034
    Analysis of MDS results.

    Analysis of MDS results. by Ying Shen (48310)

    Published 2024
    Save to List
    Saved in:
  15. 14035
    Growth with Cu(II) alters metabolite pools.

    Growth with Cu(II) alters metabolite pools. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  16. 14036
    Concentrations of <sup>13</sup>C carbon atoms in select metabolites after growth in TSB medium containing <sup>13</sup>C glucose.

    Concentrations of <sup>13</sup>C carbon atoms in select metabolites after growth in TSB medium containing <sup>13</sup>C glucose. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  17. 14037
    CD31 immunohistochemical staining of portal vein in each group of rats.

    CD31 immunohistochemical staining of portal vein in each group of rats. by Zixiang Wang (7548716)

    Published 2024
    Save to List
    Saved in:
  18. 14038
    The procedure of rat PVT modeling.

    The procedure of rat PVT modeling. by Zixiang Wang (7548716)

    Published 2024
    Save to List
    Saved in:
  19. 14039
    Metabolite concentrations in the <i>cop</i><sup>-</sup> and <i>cop</i><sup>-</sup> <i>apt</i>::<i>tetM</i> strains.

    Metabolite concentrations in the <i>cop</i><sup>-</sup> and <i>cop</i><sup>-</sup> <i>apt</i>::<i>tetM</i> strains. by Javiera Norambuena (137228)

    Published 2023
    Save to List
    Saved in:
  20. 14040
    Fig 3 -

    Fig 3 - by Zixiang Wang (7548716)

    Published 2024
    Save to List
    Saved in:

Search Tools: